|
EXHIBIT 10.7
SCS LICENSE AGREEMENT
This SCS License Agreement (the "Agreement"), which is agreed to
be effective as hereinafter provided, is by and between St. Jude
Medical, Inc., a Minnesota corporation having its principal place
of business at One Lillehei Plaza, St. Paul, Minnesota, 55117 ("St.
Jude"), and Boston Scientific Corporation, a Delaware corporation
having its principal place of business at One Boston Scientific
Place, Natick Massachusetts, 01760-1537 ("BSC").
RECITALS
A. Advanced
Bionics Corporation ("ABS"), a wholly-owned subsidiary of BSC and
Advanced Neuromodulation Systems, Inc. ("ANS"), a wholly-owned
subsidiary of St. Jude, are adverse parties in the following
currently pending litigation matters (collectively referred to as
the "SCS Cases"):
-
-
-
-
1) Advanced Neuromodulation Systems, Inc.
v. Advanced Bionics Corporation , Civil Action No. 4:04cv131
(E.D. Tex);
2) Advanced Bionics Corporation v. Advanced
Neuromodulation System, Inc. , Civil Action No. 4:04cv131 (E.D.
Tex.); and
3) the arbitration proceeding before the
International Institute for Conflict Prevention and Resolution,
Case No. G-06-08A.
B. St.
Jude and BSC and certain of their respective Affiliates are engaged
in, inter alia , the design, development, manufacture, and
sale of devices for spinal cord stimulation.
C. St.
Jude and BSC and certain of their respective Affiliates own or hold
certain rights in the Patents-In-Suit.
D. Pursuant
to a Settlement Agreement dated July 29, 2006, St. Jude and BSC
have agreed to terminate the SCS Cases in return for, inter
alia , the granting of certain rights by and between St. Jude
and BSC concerning the Patents-In-Suit (the "Settlement
Agreement").
Now therefore, in consideration of the covenants and agreements
set forth herein and the Settlement Agreement, pursuant to which a
number of additional cases between St. Jude and BSC are either
resolved or limited in scope, and for valuable consideration
receipt of which is hereby acknowledged, St. Jude and BSC mutually
agree as follows:
ARTICLE I
Definitions of Certain Terms
For the purposes of this Agreement, the following terms shall
have the meaning specified below. Whenever used in the Agreement,
"include," "includes," and "including" shall be deemed to be
followed by "without limitation," whether or not it is followed by
such words.
Section 1.01 . Affiliate .
"Affiliate" means any person or entity that controls or is
controlled by or is under common control with St. Jude or BSC on
the Effective Date or at any time thereafter. For purposes of this
Section 1.01, ownership, directly or indirectly, of more than fifty
percent (50%) of the capital stock or other comparable ownership
interest of the corporation or entity carrying the right to vote
for or appoint directors or their equivalent (if not a corporation)
shall constitute control thereof. "Affiliate" of a third party
means a person or entity that controls, is controlled by, or under
common control with, such third party.
Section 1.02 . Patents-In-Suit . "Patents-In-Suit"
means U.S. Patent Nos. 6,516,227; 6,381,496; 6,216,045; 6,154,678;
and 4,793,353.
Section 1.03 . BSC Licensed
Patents .
(a) "BSC
Licensed Patents" means U.S. Patent Nos. 6,516,227 and 6,381,496,
including all divisionals, continuations, continuations-in-part,
reissues, reexaminations and foreign counterparts, except as set
forth in Section 1.03(c), below.
(b) Without
limiting the foregoing, the term "BSC Licensed Patents"
specifically includes, but is not limited to, all present patents
and patent applications listed on Exhibit A of this Agreement. BSC
believes that Exhibit A is a complete listing of its U.S. patents
and patent applications within the foregoing definition of BSC
Licensed Patents which are in existence as of the Effective Date,
and any errors, overinclusions, or omissions from Exhibit A will be
deemed to be inadvertent and not a material breach. Present foreign
patents and patent applications, including foreign counterparts of
U.S. patents and patent applications listed on Exhibit A, have
intentionally not been included in Exhibit A but are deemed to be
BSC Licensed Patents if they are covered by the foregoing
definition in this Section 1.03.
(c) Notwithstanding
the foregoing, the term "BSC Licensed Patents" specifically
excludes the following:
|
|
(1)
|
Claims 3-15 and 20-53 of U.S.
Patent No. 6,516,227;
|
|
|
(2)
|
Claims 2, 6 and 10 of U.S. Patent
No. 6,895,280; and
|
-
-
(3) any
patent claim with priority based on U.S. Patent Nos. 6,516,227 or
6,895,280 that claims multiple independent current sources for
generating independently-controlled stimulus currents on multiple
electrodes, thereby having the equivalent function to the device as
claimed in any of the claims excluded pursuant to sub-sections (1)
and (2), above.
Section 1.04 . St. Jude Licensed
Patents .
(a) "St.
Jude Licensed Patents" means U.S. Patent Nos. 6,154,678 and
4,793,353, including all divisionals, continuations,
continuations-in-part, reissues, reexaminations and foreign
counterparts.
(b) "St.
Jude Licensed Patents" also means U.S. Patent No. 6,216,045,
including all divisionals, continuations, continuations-in-part,
reissues, reexaminations, and foreign counterparts, for use in the
SCS Field and excludes any use outside of the SCS Field.
(c) Without
limiting the foregoing, the term "St. Jude Licensed Patents"
specifically includes, but is not limited to, all present patents
and patent applications listed on Exhibit A of this Agreement. St.
Jude believes that Exhibit A is a complete listing of its U.S.
patents and patent applications within the foregoing definition of
St. Jude Licensed Patents which are in existence as of the
Effective Date, and any errors, overinclusions, or omissions from
Exhibit A will be deemed to be inadvertent and not a material
breach. Present foreign patents and patent applications, including
foreign counterparts of U.S. patents and patent applications listed
on Exhibit A, have intentionally not been included in Exhibit A but
are deemed to be St. Jude Licensed Patents if they are covered by
the foregoing definition in this Section 1.04.
Section 1.05 . SCS Field . "SCS Field" shall mean
spinal cord stimulation to treat or manage chronic pain of the
trunk and limbs.
Section 1.06 . Effective Date .
"Effective Date" shall mean July 29, 2006.
ARTICLE II
Cross License
Section 2.01 . License . Subject to the
terms, conditions, and limitations set forth herein:
(a) St.
Jude grants (and will cause its Affiliates to grant) to BSC and its
Affiliates a non-exclusive, irrevocable, perpetual, fully paid-up
(except for royalties due to a third party, if any) worldwide
license or sublicense, as the case may be, without the right to
sublicense, under the St. Jude Licensed Patents to make, have made,
use, sell, have sold, offer for sale, distribute, have distributed,
and otherwise dispose of products, including supplying or causing
to be supplied components thereof for use therein, and further
including importing products, or components thereof for use
therein, into any jurisdiction where St. Jude Licensed Patents are
effective and which are manufactured in accordance with a method of
any St. Jude Licensed Patent.
(b) BSC
grants (and will cause its Affiliates to grant) to St. Jude and its
Affiliates a non-exclusive, irrevocable, perpetual, fully paid-up
(except for royalties due to a third party, if any) worldwide
license or sublicense, as the case may be, without the right to
sublicense, under the BSC Licensed Patents to make, have made, use,
sell, have sold, offer for sale, distribute, have distributed, and
otherwise dispose of products, including supplying or causing to be
supplied components thereof for use therein, and further including
importing products, or components thereof for use therein, into any
jurisdiction where BSC Licensed Patents are effective and which are
manufactured in accordance with a method of any BSC Licensed
Patent.
(c) If
any party has products made for it under the above license grant,
such products must bear its or one of its Affiliates’ trade
names or trademarks; however, such products may bear third-party
trade names or trademarks for materials or components used in such
products.
(d) The
licenses granted in this Section 2.01 shall be irrevocable except
for the specific exceptions described in the change of control
situations contemplated by provisions of Section 9.02 below.
Section 2.02 . Regarding OEM Activities . The
licenses granted or to be granted under this Article II shall not
be used in such a way as to manufacture products on an original
equipment manufacturer ("OEM") basis for any person or entity other
than St. Jude and its Affiliates or BSC
and its Affiliates. The licenses granted or to be
granted under this Article II shall apply to and for the benefit of
products manufactured by a party to this Agreement for a third
party who is licensed under the appropriate patents of the other
party to this Agreement where, and to the extent that, the third
party’s license permits such third party to "have made" such
products for such third party. Nothing in this Agreement shall
preclude the use of the licenses granted or to be granted under
this Article II by a party or its Affiliate for the purpose of
having products manufactured by a third party on an OEM basis for
such party or its Affiliate; provided, however, that such products
must bear the trademark or trade name of such party or its
Affiliate. Notwithstanding the foregoing, such products may bear
third-party trade names or trademarks for materials or components
used in such products.
Section 2.03 . Certain Conditions, Limitations and
Understandings . The licenses and sublicenses granted under
this Agreement are expressly made subject to the following
conditions, limitations and understandings:
(a) The
licenses are personal to the parties hereto, and are nonassignable
and nontransferable, except as set forth in Section 9.02 below.
(b) The
parties and their Affiliates shall have the right, in their sole
and absolute discretion, to control the maintenance, abandonment,
extension, and licensing of their own patents including the BSC
Licensed Patents and St. Jude Licensed Patents; provided however,
that no such license or other transfer of interest shall in any
manner abridge the rights of the other party granted under this
Agreement.
(c) The
owner of a BSC Licensed Patent or St. Jude Licensed Patent shall
have the right to enforce, or not to enforce, such patents in its
sole and absolute discretion against all persons and organizations
other than a party or Affiliate of a party hereto.
(d) The
licenses granted herein shall not extend to any technical know-how
or design information, manufacturing, marketing, and/or processing
information or know-how, designs, drawings, mask works,
specifications, software source code, algorithms, clinical data, or
other documents directly or indirectly pertinent to the use of the
BSC Licensed Patents or St. Jude Licensed Patents, or to the use of
any trademarks or trade names, service marks, or software
copyrights or other copyrights (including copyright registrations)
of any party, and the parties acknowledge that there is no
obligation upon any party or its Affiliates to provide such
information, know-how, designs, drawings, mask works,
specifications, software source code, algorithms, clinical data, or
other documents.
(e) Except
as otherwise expressly provided in this Agreement, all licenses are
granted for the life of the covered patents.
(f) All
licenses and sublicenses required to be granted by Affiliates under
this Agreement shall be subject to the terms and conditions set
forth in this Agreement.
(g) Any
assignment or other transfer by a party or its Affiliate of that
entity’s interest in (i) a BSC Licensed Patent or (ii) a St.
Jude Licensed Patent shall be made subject to the rights of the
other party and its Affiliates under this Agreement.
(h) Any
license extended to an Affiliate shall continue only so long as
"Affiliate" status is maintained, or as permitted pursuant to the
other party’s consent.
ARTICLE III
Representations, Warranties and Limitations
Section 3.01 . Certain Representations and
Warranties .
(a) Each
party represents and warrants to the other party as follows and
acknowledges that each of the following representations and
warranties has been relied upon by the other party and is material
to the other party’s decision to enter into the Agreement:
each party hereto has the requisite power and authority, corporate
and otherwise, to execute and perform the Agreement, to grant the
licenses and sublicenses provided for herein, and, except as
provided in this Section 3.01, to cause such party’s
Affiliates to execute and perform the Agreement and to grant the
licenses and sublicenses provided for herein.
(b) To
the extent that a party shall lack the requisite authority to cause
an Affiliate of such party to execute or perform this Agreement or
to grant the licenses or sublicenses as provided in this Agreement,
then such party shall defend, indemnify, and hol
|